Oppenheimer & CO Inc Corcept Therapeutics Inc Transaction History
Oppenheimer & CO Inc
- $6.52 Billion
- Q4 2024
A detailed history of Oppenheimer & CO Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Oppenheimer & CO Inc holds 16,000 shares of CORT stock, worth $874,080. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,000
Previous 24,774
35.42%
Holding current value
$874,080
Previous $1.15 Million
29.67%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding CORT
# of Institutions
402Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$904 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$553 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$442 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$339 Million0.49% of portfolio
-
Parallel Advisors, LLC3.83MShares$209 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.85B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...